Completed NA INTERVENTIONAL 2-arm NCT03817359

Use of a Remifentanil-propofol Mixture in Patients Undergoing Breast Cancer Surgery

Use of a Remifentanil-propofol Mixture in Patients With Breast Cancer Undergoing Breast Cancer Surgery: a Prospective Pilot Study

Sponsor: Tri-Service General Hospital

Conditions Anesthetics Propofol Remifentanil

Interventions Remifentanil-propofol mixture

Updated 4 times since 2019 Last updated: Jan 28, 2019 Started: Aug 3, 2018 Primary completion: Dec 27, 2018 Completion: Dec 27, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Anesthetics and Propofol and is currently completed. Tri-Service General Hospital leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2019 — Jan 2021 [monthly]

Completed NA

First recorded

Aug 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tri-Service General Hospital

Data source: Tri-Service General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan